Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking therapy shows promise for autism Self-Harm

NCT ID NCT04737707

Symptom relief Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 5-month program of dialectical behavior therapy (DBT) can help adults with autism who struggle with self-harm or suicidal thoughts. Researchers enrolled 92 adults with autism and no intellectual disability. The goal was to see if DBT reduces emotional dysregulation and harmful behaviors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dialectical Behavior Therapy (DBT)
What this could lead to
If it works, this could offer a new way to help adults with autism manage intense emotions and reduce self-harm.
What could go wrong
This is a small, completed trial with 92 people, so results may not apply to everyone. DBT requires time and effort, and not everyone may benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

92 people

The number who actually took part.

Started

Apr 2021

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥ 18 years old * ASD diagnosis according to the DSM-5 * IQ ≥ 70 * Suicidal ideas, suicidal attempts and/or self-harm behaviors 6 months prior to the inclusion * Able to understand and consent to the research aims * Membership in a health insurance fund Exclusion Criteria: * complete hospitalization * ongoing CBT or DBT * past DBT * schizophrenia disorders * under guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder without intellectual disability are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder autism spectrum disorder 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorders

Contacts and locations

Locations

  • Service de psychiatrie

    Strasbourg, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.